Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Single-Center, Open-Label, Induction Dose Study of ABP-700 in Healthy, Adult Subjects

Next Previous
Search
Trial Profile

A Phase 1, Single-Center, Open-Label, Induction Dose Study of ABP-700 in Healthy, Adult Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 08 Feb 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cyclopropyl-methoxycarbonylmetomidate (Primary) ; Fentanyl (Primary) ; Midazolam (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions
  • Sponsors The Medicines Company

    • Most Recent Events

    • 01 Jan 2021 Results (n=350) from NTR4545, NTR4735, NTR5173, NTR5231, and NTR5442 modeling the effect of excitation on depth of anesthesia in ABP-700, published in the Anesthesiology
    • 13 Oct 2016 According to The Medicines Company media release, data from this trial will be presented at the International Society for Anaesthetic Pharmacology 25th Annual Meeting (ISAP) 2016.
    • 14 Jun 2016 Status changed from recruiting to completed, according to The Medicines Company media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top